Sarepta Therapeutics | Créances Commerciales

Trade Debtors Changement Date
Acadia Pharmaceuticals USD 102.35M 7.82M 2023-12
Agios Pharmaceuticals USD 2.81M 1.63M 2023-12
Alnylam Pharmaceuticals USD 327.79M 2.34M 2023-12
Amgen USD 7.27B 1.12B 2023-12
Biogen USD 2.1B 109.7M 2023-12
BioMarin Pharmaceutical USD 633.7M 61.21M 2023-12
Daiichi Sankyo JPY 411.77B 21.26B 2023-09
Eli Lilly USD 10.36B 1.19B 2023-09
Gilead Sciences USD 4.66B 130M 2023-12
Incyte USD 743.56M 86.29M 2023-12
Insmed USD 41.19M 5.61M 2023-12
Ionis Pharmaceuticals USD 97.78M 44.58M 2023-12
Moderna USD 1.08B 1.07B 2023-12
Neurocrine Biosciences USD 417.8M 30.2M 2023-09
Pfizer USD 15B 1.58B 2023-09
PTC Therapeutics USD 160.82M 4.9M 2023-12
Regeneron Pharmaceuticals USD 5.67B 82.8M 2023-12
Roche Holding CHF 11.36B 560M 2023-06
Sarepta Therapeutics USD 354.26M 87.1M 2023-09
Ultragenyx Pharmaceutical USD 79.26M 8.74M 2023-09
Vertex Pharmaceuticals USD 1.54B 17.5M 2023-09



Sarepta Therapeutics Créances Commerciales - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2024.